IP Verse

Treatment Regimen Utilizing Neratinib For Breast Cancer - EP3000467

PATENT ANALYSIS

Patent Details

Grant Date
Mar 1, 2023
Company
WYETH LLC
Oppositions

ALFRED E. TIEFENBACHER (GMBH & CO. KG)

GENERICS [UK] LIMITED

HEXAL AG

More patents of Wyeth Llc

EP2676679

EP3246044

EP3175853

Want to monitor this patent?

Feel free to send us a message here and we will get back to you